Your browser doesn't support javascript.
loading
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.
Lebofsky, Ronald; Decraene, Charles; Bernard, Virginie; Kamal, Maud; Blin, Anthony; Leroy, Quentin; Rio Frio, Thomas; Pierron, Gaëlle; Callens, Céline; Bieche, Ivan; Saliou, Adrien; Madic, Jordan; Rouleau, Etienne; Bidard, François-Clément; Lantz, Olivier; Stern, Marc-Henri; Le Tourneau, Christophe; Pierga, Jean-Yves.
Affiliation
  • Lebofsky R; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France.
  • Decraene C; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France; CNRS UMR144, Institut Curie, Paris, France.
  • Bernard V; ICGex NGS Platform, Institut Curie, Paris, France.
  • Kamal M; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France.
  • Blin A; ICGex NGS Platform, Institut Curie, Paris, France.
  • Leroy Q; ICGex NGS Platform, Institut Curie, Paris, France.
  • Rio Frio T; ICGex NGS Platform, Institut Curie, Paris, France.
  • Pierron G; Oncogenetic Laboratory, Institut Curie, Paris, France.
  • Callens C; Oncogenetic Laboratory, Institut Curie, Paris, France.
  • Bieche I; Oncogenetic Laboratory, Institut Curie, Paris, France.
  • Saliou A; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France.
  • Madic J; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France.
  • Rouleau E; Oncogenetic Laboratory, Institut Curie, Paris, France.
  • Bidard FC; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France.
  • Lantz O; INSERM U932, Institut Curie, Paris, France; CIC-BT-507, Institut Curie, Paris, France.
  • Stern MH; INSERM U830, Institut Curie, Paris, France.
  • Le Tourneau C; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France; INSERM U900, Institut Curie, Paris, France.
  • Pierga JY; Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France; University Paris Descartes, Paris, France. Electronic address: jean-yves.pierga@curie.fr.
Mol Oncol ; 9(4): 783-90, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25579085
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Precision Medicine / Genotyping Techniques / Neoplastic Cells, Circulating / Neoplasms Type of study: Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2015 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Precision Medicine / Genotyping Techniques / Neoplastic Cells, Circulating / Neoplasms Type of study: Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2015 Document type: Article Affiliation country: France Country of publication: United States